<DOC>
	<DOCNO>NCT02623556</DOCNO>
	<brief_summary>720 case TB ( Tuberculosis patient ) participant 360 case non-TB participant lung disease meet standard divide different group randomize blind method . Every subject inject intradermally ESAT6-CFP10 TB-PPD ( tuberculin purify protein derivative ) different arm person blind method . Specific gama-interferon ( Î³-IFN ) detection need injection.Measure induration ( ) redness longitudinal diameter size transverse diameter vernier caliper vernier caliper injection 24h , 48h 72h . At time , observe kind adverse event .</brief_summary>
	<brief_title>Clinical Study Recombinant Mycobacterium Tuberculosis ESAT6-CFP10 Allergen</brief_title>
	<detailed_description>Firstly , 720 case TB ( Tuberculosis ) participants meet standard respectively divide different group randomize blind method . 1 . ESAT6-CFP10 ( 10ug/ml ) leave arm 2 . ESAT6-CFP10 ( 10ug/ml ) right arm . Inject intradermally ESAT6-CFP10 TB-PPD different arm participant . For participant , person clinical research , study uniform every subject inject firstly left arm , observe obvious adverse reaction , another drug inject right arm . Measure induration ( ) redness longitudinal diameter size transverse diameter vernier caliper vernier caliper injection 24h , 48h 72h . At time , observe vital sign ( breathe , heart rate , blood pressure temperature ) , local reaction ( rash , pain , itch skin mucous membrane ) variety adverse event . Secondly , 360 case non-TB participant lung disease divide two different group procedure 720 case TB . Finally , calculate sensitivity ( positive coincidence rate ) TB ( Tuberculosis patient ) , specificity ( negative coincidence rate ) non-TB participant lung disease , verify safety effectiveness ESAT6-CFP10 ( 10ug/ml ) clinical auxiliary diagnosis tuberculosis .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Mycobacterium Infections</mesh_term>
	<criteria>Inclusion Criteria TB ( tuberculosis : include pulmonary tuberculosis extra pulmonary tuberculosis ) subject : judge pulmonary tuberculosis patient accord Health industry standard People 's Republic China WS2882008 : Diagnostic Criteria pulmonary tuberculosis ; 18 65 year old , gender limit ; Consent sign informed consent form ( ICF ) ; Comply followup . Inclusion Criteria extra pulmonary tuberculosis subject : Diagnosed extra pulmonary tuberculosis epidemiology , imaging , clinical symptom , pathological examination ; Lesions outside lung ; unfinished reinforce phase chemotherapy ; Exclusion Criteria TB ( tuberculosis ) subject : Accompanied follow severe illness : advanced cancer , diabetes , copd acute episode , acute/progressive liver disease kidney disease , congestive heart failure , ect ; Taking part clinical within three month involve clinical ; Severe allergic constitution : allergic two drug ; pregnancy lactation ; mental illness ; Any condition affect trial evaluation investigator 's judgement . Inclusion Criteria nonTB participant lung disease : A clear lung disease exclude pulmonary tuberculosis clinical symptom , image , laboratory examination . 18 65 year old , gender limit ; Consent sign informed consent form ( ICF ) ; Comply followup . Exclusion Criteria nonTB participant lung disease : Accompanied follow severe illness : advanced cancer , diabetes , copd acute episode , acute/progressive liver disease kidney disease , congestive heart failure , ect ; Taking part clinical within three month involve clinical ; Severe allergic constitution : allergic two drug ; pregnancy lactation ; mental illness ; history tuberculosis ; Any condition affect trial evaluation investigator 's judgement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>diagnosis tuberculosis</keyword>
	<keyword>ESAT6-CFP10</keyword>
	<keyword>skin test</keyword>
	<keyword>diagnostic test</keyword>
</DOC>